Development of Focal Nodular Hyperplasia Post Dual Anti-HER2 Blockade with Pertuzumab and Trastuzumab in a Patient with Breast Cancer: A Case Report and Literature Review

Targeted therapies like trastuzumab and pertuzumab have substantially improved outcomes in HER2-positive breast cancer with rare reports of significant adverse events. One such rarely reported adverse event is focal nodular hyperplasia (FNH), an uncommon hepatic condition, typically benign and asymp...

Полное описание

Библиографические подробности

Главные авторы:	Udip Maheshwari, Disha Morzaria, Vashishth Maniar, Ritu Dave, Nikhat Shaikh, Bhavin Jankharia, Karthik Ganesan
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Thieme Medical and Scientific Publishers Pvt. Ltd.
Серии:	Indian Journal of Medical and Paediatric Oncology
Предметы:	breast cancer dual anti-HER2 blockade focal nodular hyperplasia pertuzumab trastuzumab
Online-ссылка:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1802637
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!